Sign In
Buy AFIB
$0.0001
+0 (+0%)
At Close: Jul 31, 2026
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
08:35am, Tuesday, 05'th Jul 2022 Benzinga
Gainers
Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64.
Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Fast Radius, Inc. (NASDAQ: FSRD) jumped 41.2
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:01pm, Friday, 01'st Jul 2022 GlobeNewswire Inc.
CARLSBAD, Calif., July 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arr
Why Is Akebia Therapeutics Surging By 28%? 48 Stocks Moving In Friday's Mid-Day Session
04:06pm, Friday, 01'st Jul 2022 Benzinga
Gainers
Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) rose 56.1% to $ 0.7029 after dropping 10% on Thursday.
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 49.3% to $0.2852. Allena Pharmaceuticals
Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities
10:30am, Friday, 01'st Jul 2022 GlobeNewswire Inc.
CARLSBAD, Calif., July 01, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arr
This Healthcare Stock Jumps Around 188%, Here's 83 Biggest Movers From Yesterday
08:23am, Tuesday, 28'th Jun 2022 Benzinga
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) shares jumped 187.7% to close at $1.07 on Monday amid the Supreme Court overturning Roe V Wade.
Acutus Medical, Inc. (NASDAQ: AFIB) climbed 87.6% to cl
Why Is NeuroSense Therapeutics Surging By 70%? 46 Stocks Moving In Monday's Mid-Day Session
04:26pm, Monday, 27'th Jun 2022 Benzinga
Gainers
Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 87.3% to $0.6965 amid the Supreme Court overturning Roe V Wade.
Acutus Medical, Inc. (NASDAQ: AFIB) gained 82.4% to $0.9819 after the company anno
Penny Stocks To Watch: Why EVFM, AGRX, CYBN, HILS & AFIB Stock Are Moving
01:05pm, Monday, 27'th Jun 2022 PennyStocks
Penny stocks to watch with news
The post Penny Stocks To Watch: Why EVFM, AGRX, CYBN, HILS & AFIB Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Is Acutus Medical (AFIB) Stock Up 100% Today?
11:45am, Monday, 27'th Jun 2022
AFIB stock traders are celebrating as the FDA clears its arrhythmia management product for commercialization. The post Why Is Acutus Medical (AFIB) Stock Up 100% Today?
Penny Stocks To Watch: Why EVFM, AGRX, CYBN, HILS & AFIB Stock Are Moving
09:05am, Monday, 27'th Jun 2022
Penny stocks to watch with news The post Penny Stocks To Watch: Why EVFM, AGRX, CYBN, HILS & AFIB Stock Are Moving appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Why Acutus Medical Shares Are Rallying Today?
08:05am, Monday, 27'th Jun 2022
Acutus Medical Inc (NASDAQ: AFIB) has launched an expanded suite of left-heart access products, including the AcQCross Qx system for use with the TruSeal and FXD delivery system for the Watchman LAA
Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System
12:00pm, Friday, 13'th May 2022 GlobeNewswire Inc.
CARLSBAD, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Acutus Medical (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, today a
Acutus Medical, Inc. (AFIB) Q1 2022 Earnings Call Transcript
04:00am, Friday, 13'th May 2022 The Motley Fool
AFIB earnings call for the period ending March 31, 2022.
Acutus Medical, Inc. (AFIB) CEO Vince Burgess on Q2 2022 Results - Earnings Call Transcript l: ZIP
10:43pm, Thursday, 12'th May 2022
Acutus Medical, Inc. (NASDAQ:AFIB ) Q2 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Caroline Corner - IR Scott Huennekens - Chairman David Roman - Interim CEO and CFO Con
Acutus Medical, Inc. (AFIB) Reports Q1 Loss, Tops Revenue Estimates
09:35pm, Thursday, 12'th May 2022 Zacks Investment Research
Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of -1.01% and 29.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Acutus Medical, Inc. (AFIB) Reports Q1 Loss, Tops Revenue Estimates
06:48pm, Thursday, 12'th May 2022
Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of -1.01% and 29.39%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
